| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
American Journal of Clinical Nutrition, Vol 55, 1147-1153, Copyright © 1992 by The American Society for Clinical Nutrition, Inc
ORIGINAL RESEARCH COMMUNICATIONS |
JF Gregory 3d, SD Bhandari, LB Bailey, JP Toth, TG Baumgartner and JJ Cerda
Food Science and Human Nutrition Department, University of Florida, Gainesville 32611-0163.
The bioavailability of orally administered monoglutamyl folic acid and various (6S)-tetrahydrofolates was examined in humans with stable- isotope methods. Folic acid (PteGlu), tetrahydrofolate (H4folate), 5- formyl-H4folate, 10-formyl-H4folate, and 5-methyl-H4folate were prepared for oral administration in 3',5'-2H2 labeled (d2) form, and [glu-2H4]folic acid (d4-PteGlu) was prepared for intravenous injection. In each of five trials, fasting adult males (n = 7) on a folate saturation regimen (2 mg/d) were given a single oral dose of one of the d2-folates in apple juice, as well as an intravenous injection of d4- PteGlu as a control. Urine was collected for 48 h and the isotope labeling of urinary folates determined by mass spectrometry. Isotope excretion ratios of urinary folates were used as criteria of bioavailability (pooled SE = 0.10): PteGlu (1.53, least squares mean), 10-formyl-H4folate (1.02), 5-methyl-H4folate (0.99), 5-formyl-H4folate (0.1.13), and H4folate (0.71). These results indicate that differences exist in the bioavailability of monoglutamyl folates under these experimental conditions. This variation, whether due to differences in absorption or postabsorptive events, must be considered in quantitative studies of folate utilization with this type of protocol.
This article has been cited by other articles:
|
|
 |
|
  L. A Houghton, K. L Sherwood, R. Pawlosky, S. Ito, and D. L O'Connor [6S]-5-Methyltetrahydrofolate is at least as effective as folic acid in preventing a decline in blood folate concentrations during lactation. Am. J. Clinical Nutrition, April 1, 2006; 83(4): 842 - 850. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. Lim, M. Schenk, L. E. Kelemen, S. Davis, W. Cozen, P. Hartge, M. H. Ward, and R. Stolzenberg-Solomon Dietary Determinants of One-Carbon Metabolism and the Risk of Non-Hodgkin's Lymphoma: NCI-SEER Case-Control Study, 1998-2000 Am. J. Epidemiol., November 15, 2005; 162(10): 953 - 964. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Pentieva, H. McNulty, R. Reichert, M. Ward, J. J. Strain, D. J. McKillop, J. M. McPartlin, E. Connolly, A. Molloy, K. Kramer, et al. The Short-Term Bioavailabilities of [6S]-5-Methyltetrahydrofolate and Folic Acid Are Equivalent in Men J. Nutr., March 1, 2004; 134(3): 580 - 585. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. M Finglas, C. M Witthoft, L. Vahteristo, A. J. A. Wright, S. Southon, F. A. Mellon, B. Ridge, and P. Maunder Use of an Oral/Intravenous Dual-Label Stable-Isotope Protocol to Determine Folic Acid Bioavailability from Fortified Cereal Grain Foods in Women J. Nutr., May 1, 2002; 132(5): 936 - 939. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. F. Gregory III Case Study: Folate Bioavailability J. Nutr., April 1, 2001; 131(4): 1376S - 1382. [Abstract] [Full Text]
|
|
|
|
|
|
R. Prinz-Langenohl, A. Brönstrup, B. Thorand, M. Hages, and K. Pietrzik Availability of Food Folate in Humans J. Nutr., April 1, 1999; 129(4): 913 - 916. [Abstract] [Full Text]
|
|
|
|
|
|
L. M. Rogers, C. M. Pfeiffer, L. B. Bailey, and J. F. Gregory III A Dual-Label Stable-Isotopic Protocol Is Suitable for Determination of Folate Bioavailability in Humans: Evaluation of Urinary Excretion and Plasma Folate Kinetics of Intravenous and Oral Doses of [13C5] and [2H2]Folic Acid J. Nutr., December 1, 1997; 127(12): 2321 - 2327. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
